Hepatitis C hypervariable region 1: Association of reduced selection pressure in African Americans with treatment failure

Vicki M. Park, Barbara C. Mason, Julia Krushkal, Rongling Li, Caroline Riely, Jaquelyn Fleckenstein

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

In a prospective therapeutic trial, features of the hepatitis C quasispecies were investigated as possible markers of therapeutic response. Individuals chronically infected with hepatitis C genotype 1 received antiviral therapy consisting of α-interferon plus ribavirin. The study targeted the most rapidly evolving segment of the viral genome, hypervariable region 1 within the envelope-2 gene. Among individuals failing to clear virus in response to therapy, significant differences were observed between quasispecies of African-American and Caucasian subjects. While distance measures for synonymous substitutions were similar between racial subgroups, measures of distance at the amino acid level (nonsynonymous substitutions) varied significantly. Taken together, the observed patterns of variability corresponded to reduced host selection pressure against hypervariable region 1 in African-American nonresponders. Reduced selection pressure was present at baseline and persisted through treatment and follow-up, suggesting population stratification of host factors that influence selection pressure on hepatitis C virus.

Original languageEnglish
Pages (from-to)2540-2549
Number of pages10
JournalDigestive diseases and sciences
Volume52
Issue number10
DOIs
StatePublished - Oct 2007

Keywords

  • African American
  • Caucasian
  • Hepatitis C
  • Hypervariable region 1
  • Nonsynonymous substitution
  • Selection pressure

Fingerprint

Dive into the research topics of 'Hepatitis C hypervariable region 1: Association of reduced selection pressure in African Americans with treatment failure'. Together they form a unique fingerprint.

Cite this